Advertisement
OtherMinireview

RNAi Based Therapeutics and Novel RNA Bioengineering Technologies

Gavin M. Traber and Ai-Ming Yu
Journal of Pharmacology and Experimental Therapeutics June 9, 2022, JPET-MR-2022-001234; DOI: https://doi.org/10.1124/jpet.122.001234

Article Information

JPET-MR-2022-001234
DOI 
https://doi.org/10.1124/jpet.122.001234
PubMed 
35680378
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online June 9, 2022.

Article Versions

Copyright & Usage 
© 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited and is not used for commercial purposes.

Author Information

  1. Gavin M. Traber1 and
  2. Ai-Ming Yu2,*
  1. 1Biochemistry and Molecular Medicine, gmtraber@ucdavis.edu, United States
  2. 2Department of Biochemistry & Molecular Med, UC Davis School of Medicine, United States
  1. ↵* Corresponding Author:
    Ai-Ming Yu, Department of Biochemistry & Molecular Med, UC Davis School of Medicine, 2700 Stockton Blvd. Suite 2130, Oak Park Research Building, Sacramento, California, 95817, United States. E-mail: aimyu{at}ucdavis.edu

Statistics from Altmetric.com

Article usage

Article usage: June 2022 to March 2023

AbstractFullPdf
Jun 20224400183
Jul 2022162088
Aug 2022310071
Sep 2022128068
Oct 2022150062
Nov 2022162096
Dec 2022138181148
Jan 2023241374241
Feb 2023158266212
Mar 202394141133

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherMinireview

RNAi Therapeutics and Novel RNA Bioengineering Technologies

Gavin M. Traber and Ai-Ming Yu
Journal of Pharmacology and Experimental Therapeutics June 9, 2022, JPET-MR-2022-001234; DOI: https://doi.org/10.1124/jpet.122.001234
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement